Viewing Study NCT03341767


Ignite Creation Date: 2025-12-25 @ 12:37 AM
Ignite Modification Date: 2026-03-14 @ 6:19 AM
Study NCT ID: NCT03341767
Status: TERMINATED
Last Update Posted: 2019-08-13
First Post: 2017-10-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 2A Evaluation of the Safety, Tolerability, Pharmacokinetics, Efficacy of Clofazimine (CFZ) in Cryptosporidiosis
Sponsor: University of Washington
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: CFZ-001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None INDUSTRY View